PMB-676 Trademark

Trademark Overview


On Monday, September 8, 2025, a trademark application was filed for PMB-676 with the United States Patent and Trademark Office. The USPTO has given the PMB-676 trademark a serial number of 99379943. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Thursday, January 29, 2026. This trademark is owned by Pharmalink International Limited. The PMB-676 trademark is filed in the Pharmaceutical Products category with the following description:

Dietetic food and substances adapted for medical use; dietary and food supplements for humans; pharmaceutical preparations and products and natural medicines for humans for promoting brain health and cognitive function in humans; natural medicines for humans containing extracts from green lipped mussels, shellfish or krill for promoting brain health and cognitive function in humans; dietetic substances based on extracts from green lipped mussels, shellfish or krill, namely, powder, paste, tablets and solutions adapted for human use; nutraceuticals, including nutraceuticals based on krill oil extracts, green lipped mussels extracts or shellfish extracts; krill oil extracts, shell fish extracts and green lipped mussels extracts for medical, nutraceutical and pharmaceutical use; krill oil extracts, shell fish extracts and green lipped mussels extracts for use in dietary supplements for humans; krill oil extracts, shell fish extracts and green lipped mussels extracts for use in dietetic f...
pmb-676

General Information


Serial Number99379943
Word MarkPMB-676
Filing DateMonday, September 8, 2025
Status641 - NON-FINAL ACTION - MAILED
Status DateThursday, January 29, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesDietetic food and substances adapted for medical use; dietary and food supplements for humans; pharmaceutical preparations and products and natural medicines for humans for promoting brain health and cognitive function in humans; natural medicines for humans containing extracts from green lipped mussels, shellfish or krill for promoting brain health and cognitive function in humans; dietetic substances based on extracts from green lipped mussels, shellfish or krill, namely, powder, paste, tablets and solutions adapted for human use; nutraceuticals, including nutraceuticals based on krill oil extracts, green lipped mussels extracts or shellfish extracts; krill oil extracts, shell fish extracts and green lipped mussels extracts for medical, nutraceutical and pharmaceutical use; krill oil extracts, shell fish extracts and green lipped mussels extracts for use in dietary supplements for humans; krill oil extracts, shell fish extracts and green lipped mussels extracts for use in dietetic foods and substances for medical use; active ingredients in the form of fatty acids extracted from green lipped mussels, shellfish or krill for use in pharmaceutical or nutraceutical preparations

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, September 8, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePharmalink International Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCentral
HK

Trademark Events


Event DateEvent Description
Monday, September 8, 2025NEW APPLICATION ENTERED
Monday, September 8, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, September 8, 2025APPLICATION FILING RECEIPT MAILED
Wednesday, January 21, 2026ASSIGNED TO EXAMINER
Thursday, January 29, 2026NON-FINAL ACTION WRITTEN
Thursday, January 29, 2026NON-FINAL ACTION E-MAILED
Thursday, January 29, 2026NOTIFICATION OF NON-FINAL ACTION E-MAILED